Moderna Inc (MRNA) stock news · rev $145.0M
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
This MRNA news page leads with what Moderna Inc filed — not a scraped headline mill.
No cached 8-K sentence for MRNA yet. We will not pad this page with generic market recap.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MRNA stock page; for the tape open the quote page.
MRNA cached headlines
- Jim Cramer Explains Why Heavily Shorted Moderna (MRNA) Has Room to Run — Yahoo Finance
- Novartis Rises as $3.22 Billion Deal Targets Faster Drug Delivery — Yahoo Finance
- Transgene and Nec Report 100% Three-Year Disease-Free Survival with TG4050 and Publish Phase 1 Results in Nature Communications — Yahoo Finance
- Alumis' Share Price Fall After Envudeucitinib Trial Data Likely Overreaction, Oppenheimer Says — Yahoo Finance
- Why Is Vertex (VRTX) Up 14.4% Since Last Earnings Report? — Yahoo Finance
- Why Is Keros Therapeutics (KROS) Up 8% Since Last Earnings Report? — Yahoo Finance
- Krystal Biotech (KRYS) Up 12% Since Last Earnings Report: Can It Continue? — Yahoo Finance
- Indivior Pharmaceuticals Inc. (INDV) Down 5.3% Since Last Earnings Report: Can It Rebound? — Yahoo Finance
- Why Is Jazz (JAZZ) Down 6.9% Since Last Earnings Report? — Yahoo Finance
- Why Is CRISPR Therapeutics (CRSP) Up 7.1% Since Last Earnings Report? — Yahoo Finance
- European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading — Yahoo Finance
- GSK to Advance mRNA Influenza Vaccine Into Phase III Development — Yahoo Finance
Not investment advice.